Beacon Pointe Advisors’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465 Hold
11,500
– – ﹤0.01% 1914
2026
Q1
$922 Buy
+11,500
New +$1.06K ﹤0.01% 1830
2025
Q3
– Sell
-11,500
Closed -$921 – 1536
2025
Q2
$921 Buy
+11,500
New +$802 ﹤0.01% 1250

Other funds holding BDMDW

Beacon Pointe Advisors's BDMDW Position: Q2 2026 in Review

Beacon Pointe Advisors held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q2 2026 at 11,500 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Beacon Pointe Advisors first reported a position in BDMDW in Q2 2025 and has held it in 3 quarters since. The position peaked at $922 in Q1 2026. 29 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

  • Beacon Pointe Advisors held 11,500 shares of Baird Medical Investment Holdings Warrant worth $465 as of Q2 2026.
  • Beacon Pointe Advisors left its Baird Medical Investment Holdings Warrant share count unchanged in Q2 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1914 holding.
  • Beacon Pointe Advisors first reported a position in Baird Medical Investment Holdings Warrant in Q2 2025 and has held it in 3 quarters since.
  • Beacon Pointe Advisors's Baird Medical Investment Holdings Warrant position peaked at $922 in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.